{"DataElement":{"publicId":"5294244","version":"1","preferredName":"Patient Next Visit Intervention Type","preferredDefinition":"The type of protocol intervention that the participant receive in the subsequent visit.","longName":"NEXT_VIST_INTVN_TP","context":"DCP","contextVersion":"1","DataElementConcept":{"publicId":"5294237","version":"1","preferredName":"Patient Next Visit Intervention or Procedure Therapy","preferredDefinition":"Subsequent; immediately following in time or order._A visit by a patient or study participant to a medical professional._An activity that produces an effect, or that is intended to alter the course of a disease in a patient or population. This is a general term that encompasses the medical, social, behavioral, and environmental acts that can have preventive, therapeutic, or palliative effects._An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.","longName":"5294235v1.0:2940267v1.0","context":"DCP","contextVersion":"1","ObjectClass":{"publicId":"5294235","version":"1","preferredName":"Next Patient Visit","preferredDefinition":"Subsequent; immediately following in time or order.:A visit by a patient or study participant to a medical professional.","longName":"C53286:C39564","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Next","conceptCode":"C53286","definition":"Subsequent; immediately following in time or order.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Patient Visit","conceptCode":"C39564","definition":"A visit by a patient or study participant to a medical professional.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3556AD29-8F1E-C1B3-E050-BB89AD435DBF","latestVersionIndicator":"Yes","beginDate":"2016-06-15","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2016-06-15","modifiedBy":"ONEDATA","dateModified":"2016-06-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2940267","version":"1","preferredName":"Intervention or Procedure Therapy","preferredDefinition":"An activity that produces an effect, or that is intended to alter the course of a disease in a patient or population.  This is a general term that encompasses the medical, social, behavioral, and environmnetal acts that can have preventive, therapeutic, or palliative effects.:An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.","longName":"C25218:C15368","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intervention or Procedure","conceptCode":"C25218","definition":"An activity that produces an effect, or that is intended to alter the course of a disease in a patient or population. This is a general term that encompasses the medical, social, behavioral, and environmental acts that can have preventive, therapeutic, or palliative effects.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Therapy","conceptCode":"C15368","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"739F3667-A15F-16A5-E040-BB89AD43747E","latestVersionIndicator":"Yes","beginDate":"2009-09-15","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-09-15","modifiedBy":"ONEDATA","dateModified":"2009-09-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008514","version":"1","preferredName":"DCP Conceptual Domain","preferredDefinition":"DCP Conceptual Domain","longName":"DCP","context":"DCP","contextVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A946859C-932E-4C16-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-08-28","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-08-28","modifiedBy":"MAESKEB","dateModified":"2004-11-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3556AD29-8F2C-C1B3-E050-BB89AD435DBF","latestVersionIndicator":"Yes","beginDate":"2016-06-15","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2016-06-15","modifiedBy":"MAESKEB","dateModified":"2016-08-08","changeDescription":"Created for DCP May20130202, WZ 6/15/2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2744070","version":"1","preferredName":"Preventive Intervention Type","preferredDefinition":"Therapeutic, nutritional, environmental, social and or behavioral interventions at the societal, community, organizational or individual levels to reduce, modify or stop the course of a disease._Something distinguishable as an identifiable class based on common qualities.","longName":"PREV_INTR_TY","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"60","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"High-dose cytarabine","valueDescription":"High Dose Cytarabine","ValueMeaning":{"publicId":"2769705","version":"1","preferredName":"High Dose Cytarabine","longName":"2769705","preferredDefinition":"High; greater than normal in degree or intensity or amount.: The amount of medicine taken, or radiation given, at one time.: An anticancer drug that belongs to the family of drugs called antimetabolites.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"High","conceptCode":"C25227","definition":"An elevated level or position or degree; greater than normal in degree or intensity or amount.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Dose","conceptCode":"C25488","definition":"A quantity of an agent (such as substance or energy) administered, taken, or absorbed at one time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Cytarabine","conceptCode":"C408","definition":"An antimetabolite analogue of cytidine with a modified sugar moiety (arabinose instead of ribose). Cytarabine is converted to the triphosphate form within the cell and then competes with cytidine for incorporation into DNA.  Because the arabinose sugar sterically hinders the rotation of the molecule within DNA, DNA replication ceases, specifically during the S phase of the cell cycle.  This agent also inhibits DNA polymerase, resulting in a decrease in DNA replication and repair. (NCI04)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5353004C-779C-0F2B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"STURGILLJ","dateCreated":"2008-07-31","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5353004C-77B5-0F2B-E044-0003BA3F9857","beginDate":"2008-04-23","endDate":null,"createdBy":"STURGILLJ","dateCreated":"2008-07-31","modifiedBy":"STURGILLJ","dateModified":"2008-07-31","deletedIndicator":"No"},{"value":"Spinal irradiation","valueDescription":"Spinal Irradiation","ValueMeaning":{"publicId":"2749962","version":"1","preferredName":"Spinal Irradiation","longName":"2749962","preferredDefinition":"Spinal; of or relating to the spine or spinal cord.: Treatment with radiation, generally meaning exposure to ionizing radiation or radiation of wavelengths shorter than those of visible light.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Spinal","conceptCode":"C38026","definition":"Of or relating to the spine or spinal cord.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Irradiation","conceptCode":"C68775","definition":"Treatment with radiation, generally meaning exposure to ionizing radiation or radiation of wavelengths shorter than those of visible light.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4D599ED9-0E7A-72CF-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"STURGILLJ","dateCreated":"2008-05-16","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4D599ED9-0E93-72CF-E044-0003BA3F9857","beginDate":"2008-04-23","endDate":null,"createdBy":"STURGILLJ","dateCreated":"2008-05-16","modifiedBy":"STURGILLJ","dateModified":"2008-05-16","deletedIndicator":"No"},{"value":"Cranial irradiation","valueDescription":"Cranial Irradiation","ValueMeaning":{"publicId":"2750105","version":"1","preferredName":"Cranial Irradiation","longName":"2750105","preferredDefinition":"Cranial; of or relating to the cranium.: Treatment with radiation, generally meaning exposure to ionizing radiation or radiation of wavelengths shorter than those of visible light.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cranial","conceptCode":"C37936","definition":"Of or relating to the cranium.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Irradiation","conceptCode":"C68775","definition":"Treatment with radiation, generally meaning exposure to ionizing radiation or radiation of wavelengths shorter than those of visible light.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4D5CE4A1-392B-12AE-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"STURGILLJ","dateCreated":"2008-05-16","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4D5CE4A1-3944-12AE-E044-0003BA3F9857","beginDate":"2008-04-23","endDate":null,"createdBy":"STURGILLJ","dateCreated":"2008-05-16","modifiedBy":"STURGILLJ","dateModified":"2008-05-16","deletedIndicator":"No"},{"value":"Other prophylaxis","valueDescription":"Other Preventive Intervention","ValueMeaning":{"publicId":"2744071","version":"1","preferredName":"Other Preventive Intervention","longName":"2744071","preferredDefinition":"Not otherwise specified.: An attempt to prevent disease.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C0205394","definition":"Not otherwise specified.","evsSource":"UMLS_CUI","primaryIndicator":"No","displayOrder":"1"},{"longName":"Preventive Intervention","conceptCode":"C15843","definition":"Therapeutic, nutritional, environmental, social and/or behavioral interventions at the societal, community, organizational or individual levels to reduce, modify or stop the course of a disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4B8C6F93-22D3-1D38-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"STURGILLJ","dateCreated":"2008-04-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4B8C6F93-22EC-1D38-E044-0003BA3F9857","beginDate":"2008-04-23","endDate":null,"createdBy":"STURGILLJ","dateCreated":"2008-04-23","modifiedBy":"STURGILLJ","dateModified":"2008-04-23","deletedIndicator":"No"},{"value":"Intrathecal chemotherapy","valueDescription":"Intrathecal Chemotherapy","ValueMeaning":{"publicId":"2737466","version":"1","preferredName":"Intrathecal Chemotherapy","longName":"2737466","preferredDefinition":"(in-tra-THEE-kal KEE-mo-THER-a-pee) Anticancer drugs that are injected into the fluid-filled space between the thin layers of tissue that cover the brain and spinal cord.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intrathecal Chemotherapy","conceptCode":"C15750","definition":"Chemotherapy delivered via the spinal canal.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"497238FA-C36A-26E6-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"NYCHM","dateCreated":"2008-03-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4B8C6F93-2320-1D38-E044-0003BA3F9857","beginDate":"2008-04-23","endDate":null,"createdBy":"STURGILLJ","dateCreated":"2008-04-23","modifiedBy":"STURGILLJ","dateModified":"2008-04-23","deletedIndicator":"No"},{"value":"Co-trimoxazole","valueDescription":"Trimethoprim-Sulfamethoxazole","ValueMeaning":{"publicId":"2577719","version":"1","preferredName":"Trimethoprim-Sulfamethoxazole","longName":"2577719","preferredDefinition":"A combination of two anti-infection drugs, sulfamethoxazole and trimethoprim. It is used to fight bacterial and protozoal infections.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Trimethoprim-Sulfamethoxazole","conceptCode":"C909","definition":"A synthetic combination of two antibacterial agents, trimethoprim and sulfamethoxazole. This synergistic combination, also known as Co-Trimoxazole, inhibits two sequential steps in the bacterial metabolism of folic acid. Trimethoprim is a pyrimidine inhibitor of dihydrofolate reductase; sulfamethoxazole is a sulfamide inhibitor of bacterial dihydrofolate synthase.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FCA4-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-17","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-02-17","modifiedBy":"ONEDATA","dateModified":"2006-02-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A369A0EE-110B-2F9A-E040-BB89AD430C53","beginDate":"2011-05-16","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-05-16","modifiedBy":"ONEDATA","dateModified":"2011-05-16","deletedIndicator":"No"},{"value":"Antiviral drug(s)","valueDescription":"Antiviral Agent","ValueMeaning":{"publicId":"3235629","version":"1","preferredName":"Antiviral Agent","longName":"3235629","preferredDefinition":"Drugs used to treat infections caused by viruses.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Antiviral Agent","conceptCode":"C281","definition":"Any agent that can treat or prevent viral infections by interfering with the viral replication cycle.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A369A0EE-1117-2F9A-E040-BB89AD430C53","latestVersionIndicator":"Yes","beginDate":"2011-05-16","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-05-16","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A369A0EE-1132-2F9A-E040-BB89AD430C53","beginDate":"2011-05-16","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-05-16","modifiedBy":"ONEDATA","dateModified":"2011-05-16","deletedIndicator":"No"},{"value":"Antifungal drug(s)","valueDescription":"Antifungal Agent","ValueMeaning":{"publicId":"2738678","version":"1","preferredName":"Antifungal Agent","longName":"2738678","preferredDefinition":"Drugs that treat infections caused by fungi.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Antifungal Agent","conceptCode":"C514","definition":"Substances that treat systemic or topical infections caused by fungi. Antifungal agents kill or inhibit the growth of fungi, by various mechanisms. These mechanisms include inhibition of fungal mitosis, impairing synthesis or binding to ergosterol, inhibition of RNA or DNA synthesis, and interfering with other fungal metabolic processes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"49E7530B-6457-6451-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-04-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A369A0EE-1148-2F9A-E040-BB89AD430C53","beginDate":"2011-05-16","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-05-16","modifiedBy":"ONEDATA","dateModified":"2011-05-16","deletedIndicator":"No"},{"value":"High-dose methotrexate","valueDescription":"High Dose Methotrexate","ValueMeaning":{"publicId":"3685573","version":"1","preferredName":"High Dose Methotrexate","longName":"3685573","preferredDefinition":"An elevated level or position or degree; greater than normal in degree or intensity or amount.: A quantity of an agent (such as substance or energy) administered, taken, or absorbed at one time. : An antimetabolite with antineoplastic and immunomodulating properties.  Methotrxate inhibits the enzyme dihydrofolate reductase, resulting in inhibition of purine nucleotide and thymidylate synthesis and, subsequently, inhibition of DNA and RNA syntheses.  Methotrexate also exhibits potent immunosuppressant properties. (NCI04)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"High","conceptCode":"C25227","definition":"An elevated level or position or degree; greater than normal in degree or intensity or amount.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Dose","conceptCode":"C25488","definition":"A quantity of an agent (such as substance or energy) administered, taken, or absorbed at one time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Methotrexate","conceptCode":"C642","definition":"An antimetabolite and antifolate agent with antineoplastic and immunosuppressant activities. Methotrexate binds to and inhibits the enzyme dihydrofolate reductase, resulting in inhibition of purine nucleotide and thymidylate synthesis and, subsequently, inhibition of DNA and RNA syntheses. Methotrexate also exhibits potent immunosuppressant activity although the mechanism(s) of actions is unclear.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D5A0F353-0FD8-C0DA-E040-BB89AD4348BA","latestVersionIndicator":"Yes","beginDate":"2013-02-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-02-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D5A0F353-0FF1-C0DA-E040-BB89AD4348BA","beginDate":"2013-02-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-02-13","modifiedBy":"ONEDATA","dateModified":"2013-02-13","deletedIndicator":"No"},{"value":"Craniospinal irradiation","valueDescription":"Craniospinal Irradiation","ValueMeaning":{"publicId":"5028294","version":"1","preferredName":"Craniospinal Irradiation","longName":"5028294","preferredDefinition":"The use of radiation therapy directed at the brain and spinal cord to kill cancer cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Craniospinal Irradiation","conceptCode":"C116437","definition":"The use of radiation therapy directed at the brain and spinal cord to kill cancer cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2189EF50-FFA7-CB37-E050-BB89AD437EA1","latestVersionIndicator":"Yes","beginDate":"2015-10-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-10-07","modifiedBy":"KUMMEROA","dateModified":"2023-09-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"50FD5014-D7CF-4B5B-E053-F662850AC2D8","beginDate":"2017-06-02","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2017-06-02","modifiedBy":"ONEDATA","dateModified":"2017-06-02","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2749959","version":"1","preferredName":"Preventive Intervention Type","preferredDefinition":"An attempt to prevent disease.:Type; a subdivision of a particular kind of thing.","longName":"C15843:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Preventive Intervention","conceptCode":"C15843","definition":"Therapeutic, nutritional, environmental, social and/or behavioral interventions at the societal, community, organizational or individual levels to reduce, modify or stop the course of a disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4D599ED9-0E11-72CF-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-05-16","endDate":null,"createdBy":"STURGILLJ","dateCreated":"2008-05-16","modifiedBy":"ONEDATA","dateModified":"2008-05-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4B8C6F93-22BB-1D38-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-04-23","endDate":null,"createdBy":"STURGILLJ","dateCreated":"2008-04-23","modifiedBy":"NYCHM","dateModified":"2017-08-29","changeDescription":"released 8/29/17mn.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"What protocol intervention wi","type":"Preferred Question Text","description":"What protocol intervention will the participant receive in the subsequent visit?","url":null,"context":"DCP"}],"origin":"DCP:Division of Cancer Prevention","workflowStatus":"RELEASED","registrationStatus":"Application","id":"3556D241-B009-4275-E050-BB89AD430609","latestVersionIndicator":"Yes","beginDate":"2016-06-15","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2016-06-15","modifiedBy":"ZHANGWE","dateModified":"2018-07-16","changeDescription":"Created for DCP MAY02022013, WZ 6/15/2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}